Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5761 - 5768 of 12107 results
Final Opioid Package: A Comparison of the House Package, Senate Package, and the Final Version
October 2, 2018| Blog| Viewpoint
Head of the Antitrust Division of the Department of Justice Announces Plan to Expedite the Merger Review Process and Put DOJ on a 6 Month Shot Clock
October 2, 2018| Advisory| Viewpoint
Association Health Plan Perspectives (Part 2): The Look-Through Rule and the Limits of State Regulatory Power
October 2, 2018| Blog| Viewpoint
New York State Department of Labor Releases Final Guidance Just Ahead of October 9, 2018 Compliance Deadline
October 2, 2018| Blog| Viewpoint
DV-2020 Diversity Visa Registration to Open
October 2, 2018| Advisory| Viewpoint
Medical Devices and the Intersection between FDA and Patent Law
October 2, 2018| Blog| Viewpoint
ML Strategies Weekly Health Care Preview - Week of October 1, 2018
October 1, 2018| Blog| Viewpoint
News & Press Releases
Mintz Honored with NLADA Beacon of Justice Award
August 21, 2025
Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|